Authors: Alice Weatherston
Research carried out at Massachusetts General Hospital (MA, USA) has revealed that a genetic risk score may be able to detect individuals at a higher risk of Alzheimer’s disease as young as the age of 18. The findings were published recently in Neurology.
“The stage of Alzheimer’s before symptoms show up is thought to last over a decade. Given that current clinical trials are testing whether therapies can slow memory and thinking decline among people at risk for the disease, it is critical to understand the influence of risk factors before symptoms are present,” explained Elizabeth C. Mormino (Massachusetts General Hospital).